219 related articles for article (PubMed ID: 34184927)
1. Impact of Preoperative Immunonutrition on Perioperative Outcomes following Cystectomy.
Khaleel S; Regmi S; Hannah P; Watarai B; Sathianathen N; Weight C; Konety B
J Urol; 2021 Nov; 206(5):1132-1138. PubMed ID: 34184927
[TBL] [Abstract][Full Text] [Related]
2. Perioperative Immunonutrition Modulates Inflammatory Response after Radical Cystectomy: Results of a Pilot Randomized Controlled Clinical Trial.
Hamilton-Reeves JM; Stanley A; Bechtel MD; Yankee TM; Chalise P; Hand LK; Lee EK; Smelser W; Mirza M; Wyre H; Hull H; Carlson SE; Holzbeierlein JM
J Urol; 2018 Aug; 200(2):292-301. PubMed ID: 29518432
[TBL] [Abstract][Full Text] [Related]
3. Impact of Perioperative Immunonutrition on Complications in Patients Undergoing Radical Cystectomy: A Retrospective Analysis.
Cozzi G; Musi G; Milani M; Jemos C; Gandini S; Mazzoleni L; Ferro M; Luzzago S; Bianchi R; Omodeo Salé E; de Cobelli O
Integr Cancer Ther; 2021; 20():15347354211019483. PubMed ID: 34027701
[TBL] [Abstract][Full Text] [Related]
4. The effect of neoadjuvant chemotherapy on perioperative outcomes in patients who have bladder cancer treated with radical cystectomy: a population-based study.
Gandaglia G; Popa I; Abdollah F; Schiffmann J; Shariat SF; Briganti A; Montorsi F; Trinh QD; Karakiewicz PI; Sun M
Eur Urol; 2014 Sep; 66(3):561-8. PubMed ID: 24486024
[TBL] [Abstract][Full Text] [Related]
5. Comparative effectiveness of robot-assisted vs. open radical cystectomy.
Hanna N; Leow JJ; Sun M; Friedlander DF; Seisen T; Abdollah F; Lipsitz SR; Menon M; Kibel AS; Bellmunt J; Choueiri TK; Trinh QD
Urol Oncol; 2018 Mar; 36(3):88.e1-88.e9. PubMed ID: 29277584
[TBL] [Abstract][Full Text] [Related]
6. The Utility of Inflammatory Serum Markers in the Assessment of Perioperative Morbidity after Radical Cystectomy for Bladder Cancer.
Claps F; Rossin G; van Rhijn BWG; Mir MC; Mertens LS; Ongaro L; Traunero F; Iachimovsky AI; Piasentin A; Vedovo F; Perotti A; Tulone G; Zucchi A; Liguori G; Simonato A; Bartoletti R; Trombetta C; Pavan N
Medicina (Kaunas); 2023 May; 59(5):. PubMed ID: 37241158
[No Abstract] [Full Text] [Related]
7. Surgical Safety of Radical Cystectomy and Pelvic Lymph Node Dissection Following Neoadjuvant Pembrolizumab in Patients with Bladder Cancer: Prospective Assessment of Perioperative Outcomes from the PURE-01 Trial.
Briganti A; Gandaglia G; Scuderi S; Gallina A; Colombo R; Fossati N; Barletta F; Pellegrino A; Nocera L; Montorsi F; Necchi A
Eur Urol; 2020 May; 77(5):576-580. PubMed ID: 31911010
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant chemotherapy for bladder cancer does not increase risk of perioperative morbidity.
Johnson DC; Nielsen ME; Matthews J; Woods ME; Wallen EM; Pruthi RS; Milowsky MI; Smith AB
BJU Int; 2014 Aug; 114(2):221-8. PubMed ID: 24274722
[TBL] [Abstract][Full Text] [Related]
9. [ADOPTION OF ENHANCED RECOVERY AFTER SURGERY (ERAS) PROTOCOL FOR THE MANAGEMENT OF PATIENTS UNDERGOING RADICAL CYSTECTOMY IN JAPAN].
Naito Y; Kanazawa H; Okada Y; Nagayama J; Syo N; Yamamoto A; Kojima I; Terashima Y; Nagai T
Nihon Hinyokika Gakkai Zasshi; 2020; 111(1):9-15. PubMed ID: 33473094
[TBL] [Abstract][Full Text] [Related]
10. Validating the predictors of outcomes after radical cystectomy for bladder cancer.
Woldu SL; Sanli O; Clinton TN; Lotan Y
Cancer; 2019 Jan; 125(2):223-231. PubMed ID: 30291813
[TBL] [Abstract][Full Text] [Related]
11. Intracorporeal robot-assisted radical cystectomy, together with an enhanced recovery programme, improves postoperative outcomes by aggregating marginal gains.
Tan WS; Tan MY; Lamb BW; Sridhar A; Mohammed A; Baker H; Nathan S; Briggs T; Tan M; Kelly JD
BJU Int; 2018 Apr; 121(4):632-639. PubMed ID: 29124853
[TBL] [Abstract][Full Text] [Related]
12. Preoperative immunonutrition prior to radical cystectomy: a pilot study.
Lyon TD; Turner I I RM; McBride D; Wang L; Gingrich JR; Hrebinko RL; Jacobs BL; Davies BJ; Tarin TV
Can J Urol; 2017 Aug; 24(4):8895-8901. PubMed ID: 28832307
[TBL] [Abstract][Full Text] [Related]
13. Early discharge and post-discharge outcomes in patients undergoing radical cystectomy for bladder cancer.
Xia L; Taylor BL; Newton AD; Malhotra A; Pulido JE; Strother MC; Guzzo TJ
BJU Int; 2018 Apr; 121(4):583-591. PubMed ID: 29063682
[TBL] [Abstract][Full Text] [Related]
14. Impact of neoadjuvant chemotherapy on short-term complications and survival following radical cystectomy.
Milenkovic U; Akand M; Moris L; Demaegd L; Muilwijk T; Bekhuis Y; Laenen A; Van Cleynenbreugel B; Everaerts W; Van Poppel H; Dumez H; Albersen M; Joniau S
World J Urol; 2019 Sep; 37(9):1857-1866. PubMed ID: 30519746
[TBL] [Abstract][Full Text] [Related]
15. Cardiopulmonary reserve as determined by cardiopulmonary exercise testing correlates with length of stay and predicts complications after radical cystectomy.
Tolchard S; Angell J; Pyke M; Lewis S; Dodds N; Darweish A; White P; Gillatt D
BJU Int; 2015 Apr; 115(4):554-61. PubMed ID: 25109512
[TBL] [Abstract][Full Text] [Related]
16. No increased risk of short-term complications after radical cystectomy for muscle-invasive bladder cancer among patients treated with preoperative chemotherapy: a nation-wide register-based study.
Jerlström T; Chen R; Liedberg F; Andrén O; Ströck V; Aljabery FAS; Hosseini A; Sherif A; Malmström PU; Ullén A; Gårdmark T; Fall K
World J Urol; 2020 Feb; 38(2):381-388. PubMed ID: 31020424
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant chemotherapy does not increase peri-operative morbidity following radical cystectomy.
Arora A; Zugail AS; Pugliesi F; Cathelineau X; Macek P; Barbé Y; Karnes RJ; Ahmed M; Di Trapani E; Soria F; Alvarez-Maestro M; Montorsi F; Briganti A; Necchi A; Pradere B; D'Andrea D; Krajewski W; Roumiguié M; Bajeot AS; Hurle R; Contieri R; Carando R; Teoh JY; Roupret M; Benamran D; Ploussard G; Mir MC; Sanchez-Salas R; Moschini M
World J Urol; 2022 Jul; 40(7):1697-1705. PubMed ID: 35488914
[TBL] [Abstract][Full Text] [Related]
18. Alvimopan Is Associated With a Reduction in Length of Stay and Hospital Costs for Patients Undergoing Radical Cystectomy.
Huang JT; Cole AP; Mossanen M; Preston MA; Wang Y; Kibel AS; Chung BI; Huang WJ; Chang SL
Urology; 2020 Jun; 140():115-121. PubMed ID: 32268172
[TBL] [Abstract][Full Text] [Related]
19. Determining the optimal time for radical cystectomy after neoadjuvant chemotherapy.
Mmeje CO; Benson CR; Nogueras-González GM; Jayaratna IS; Gao J; Siefker-Radtke AO; Kamat AM; Dinney CP; Navai N; Shah JB
BJU Int; 2018 Jul; 122(1):89-98. PubMed ID: 29569824
[TBL] [Abstract][Full Text] [Related]
20. Risk factors of hospital readmission after radical cystectomy and urinary diversion: analysis of a large contemporary series.
Harraz AM; Osman Y; El-Halwagy S; Laymon M; Mosbah A; Abol-Enein H; Shaaban AA
BJU Int; 2015 Jan; 115(1):94-100. PubMed ID: 24905239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
